Real-world data can help resolve some challenges commonly faced in clinical trails, said Viraj Narayanan, MBA, vice president of Life Sciences at COTA Healthcare.
Real-world data can help resolve some challenges commonly faced in clinical trails, said Viraj Narayanan, MBA, vice president of Life Sciences at COTA Healthcare.
Transcript:
How can the use of real-world data help provide additional insights into patients that clinical trials miss?
So from a pre approval process, the idea of using an external comparitor for a single arm trial is really a fundamental change. The way we think about this is it's a little bit of an ethical issue. Would you want a loved one to be on a placebo arm of a cancer trial? I think most people would say no. So why can't we start using real world data as that placebo group to compare the new investigational agent that the sponsor is considering? If that really becomes a norm, we're going to see a complete rewiring of the traditional clinical trial process from a pre-approval standpoint. From a post-approval standpoint, as oncology trials have become more and more narrow, in getting approval on this narrow cohort, this is where real-world data has a really exciting role to play. We know inherently that a narrow population is not all patients. It’s just not. So from a post-approval process where real-world data can have a big impact is looking at patients that are really representative of real patients and seeing how they do, relative to the clinical trial. Are they getting the same clinical response as patients in the clinical trial? Are they getting the same safety response as patients in the clinical trial? Are there super responders, are there under responders? From a post-approval process, it's really looking at a more representative data set to see how patients are doing.
Dr Dalia Rotstein: Physicians Must Be Aware MS Affects People of All Backgrounds
April 24th 2024Dalia Rotstein, MD, MPH, emphazises the importance of awareness that multiple sclerosis (MS) impacts patients from various backgrounds as clinicians think through ways to improve access to care and research efforts in MS.
Read More
Examining Low-Value Cancer Care Trends Amidst the COVID-19 Pandemic
April 25th 2024On this episode of Managed Care Cast, we're talking with the authors of a study published in the April 2024 issue of The American Journal of Managed Care® about their findings on the rates of low-value cancer care services throughout the COVID-19 pandemic.
Listen
Beyond Insulin: The Impact of Next-Generation Diabetes Technology
April 17th 2024Experts explain how new diabetes technologies like continuous glucose monitors are transforming care beyond intensive insulin therapy, offering personalized insights and improving outcomes for patients of all treatment levels.
Read More
Empowering Community Health Through Wellness and Faith
April 23rd 2024To help celebrate and recognize National Minority Health Month, we are bringing you a special month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In the third episode, Camille Clarke-Smith, EdD, MS, CHES, CPT, discusses approaching community health holistically through spiritual and community engagement.
Listen
Increasing Lp(a) Awareness for Better Cardiovascular Health: Dr Mary McGowan
March 24th 2024For Lp(a) Awareness Day, Mary McGowan, MD, FNLA, chief medical officer of the Family Heart Foundation, highlights how most people with elevated Lp(a) are completely unaware that they have this increased risk and calls for increased testing.
Read More